Table 4ICD-9-CM and ICD-10-CM diagnosis codes defining opioid use disorder (OUD)Diagnosis codeDescriptionICD-9-CM diagnosis codes970.1Poisoning by opiate antagonistsE850.0Accidental poisoning by heroinE850.1Accidental poisoning by methadone138 more rows
2022 ICD-10-CM Diagnosis Code F19. 20: Other psychoactive substance dependence, uncomplicated.
A patient with a history of opioid abuse or dependence should be coded with the appropriate remission code (F11. 11 Opioid abuse, in remission or F11. 21 Opioid dependence, in remission).Dec 6, 2017
F13.20ICD-10-CM Code for Sedative, hypnotic or anxiolytic dependence, uncomplicated F13. 20.
Diagnosing drug addiction (substance use disorder) requires a thorough evaluation and often includes an assessment by a psychiatrist, a psychologist, or a licensed alcohol and drug counselor. Blood, urine or other lab tests are used to assess drug use, but they're not a diagnostic test for addiction.Oct 26, 2017
Whereas mild substance use disorder continues to be F1x. 10, moderate substance use disorder continues to be F1x. 20, and severe substance use disorder continues to be F1x. 20, mild substance use disorder in remission is now coded as F1x.Oct 12, 2017
81: Encounter for therapeutic drug level monitoring.
ICD-10-CM Code for Opioid abuse, uncomplicated F11.
Opioid dependence with opioid-induced mood disorder F11. 24 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The Drug Enforcement Agency (DEA) classify benzodiazepines as a Schedule IV controlled substance. According to the classification, these drugs have a low potential for abuse and low risk of dependence.Apr 9, 2020
Sedative, Hypnotic, or Anxiolytic Use Disorder is a substance use disorder characterized by repeated use of substances including benzodiazepines, benzodiazepine-like drugs (e.g. - zolpidem, zaleplon), carbamates (e.g. - glutethimide, meprobamate), barbiturates (e.g. - phenobarbital, secobarbital), and barbiturate-like ...Mar 29, 2021